Jeff Buchan (@JeffBuchan) header
Jeff Buchan (@JeffBuchan) profile picture

Responsible AI + Policy Partnerships @Anthropic. Dad, Blue Devil, Sneaker & Dessert Enthusiast, Views my own.

Chicago, IL
Joined June 2011
Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)Photo by Jeff Buchan (@JeffBuchan)
Jeff Buchan retweeted
We’re committing a portion of Anthropic’s shares to the Anthropic Public Benefit Fund, a new wholly owned entity dedicated entirely to the public benefit. It will start off with 5% of our shares. For every 50% increase in the company’s value over a set baseline, we can contribute up to an extra 2%, subject to our board’s discretion. In total, this means that roughly 20% of Anthropic’s shares are committed to the public good. Our co-founders have already pledged to donate 80% of their equity, and around half our employees are donating a portion of their equity as part of a donation matching program we’ve run since our founding. In the post below, we share more details about our new fund. anthropic.com/news/public-be…
2,296
1,744
1,688
21,518
7,806,223
Jeff Buchan retweeted
Today we announced the Claude-led discovery of a molecular machine that we suspect could represent a new gene editing mechanism. Its precise function, biotechnological utility (if any), or level of significance is not yet clear, but at minimum it is work I would have been proud to do as a PhD student. The work was done mostly, though not entirely, by Claude: our life sciences team suggested a broad area of research, Claude read through the literature and a bunch of genome data and discovered something interesting, then Claude proposed experiments to verify the discovery and our team carried them out. It’s easy to dismiss this as a one-off or curiosity, but we’ve repeatedly seen a pattern where AI performance in new intellectual domains goes from weak to superhuman in a matter of a few years. In 2023 models struggled to do math at the level of an average high-school student. In 2024 they started to do well on math competitions for the best high-schoolers in the country, in 2025 they started to solve minor open problems, in early 2026 more significant open problems, and in late 2026 they are beginning to solve the top few open problems in all of mathematics. We believe AI for biology is on a similar exponential trend. The main difference between biology and mathematics, of course, is that math can be done purely theoretically, while biology requires experimentation. Some have used this to draw the conclusion that AI’s utility in biology will be limited. We think this is wrong. As we’ve demonstrated today, humans can collaborate with AI to perform the experiments, validate key results in a few weeks and, if necessary, work with the AI to iterate on what they find. Eventually it may even be possible for Claude itself to safely perform the experiments by autonomously controlling lab equipment, with appropriate safeguards in place, but we aren’t doing that today (our lab is also a BSL1/BSL2 facility that doesn't handle materials dangerous to humans). More broadly, biomedical advancement has many stages — from fundamental biology discoveries, to translational research, to drug discovery, clinical trials, and finally the actual delivery of medicines and health care to patients. We are also interested in these later stages, but even simply accelerating the first stage of fundamental biological discoveries has the potential to speed up and broaden the entire pipeline. Improving our understanding of biology and sharpening biologists’ tools can drive forward all of the later stages, for example by identifying new drug targets, finding new therapeutic modalities, allowing for more precise measurement, and speeding up the experimental loop which itself further accelerates our understanding of biology. This will not in itself speed up clinical trial times, but if it succeeds it could greatly increase the number of promising candidates that go into the pipeline — an increase in throughput even though latency remains. In Machines of Loving Grace, I wrote about AI’s potential to “cure most diseases in 5-10 years” — a goal that sounds impossible, but one I believe is just barely possible if AI is applied to every stage of the pipeline. The first step is showing that AI can first help with, and then drive, biological discoveries. Claude’s discovery is the latest in a line of related prior work that goes back decades, beginning with systems like CRISPR, and continuing with discoveries like the bridge recombinase and VIPR in the past few years. Recently, there has been heightened interest in systems based on reverse transcriptase (RT) enzymes, the enzyme underlying the system Claude identified. And most recently, a Stanford team working independently described a novel RT system with an associated non-coding array that is in some ways similar to the one Claude found, though they are distinct systems that evolved independently from each other. I believe that we’re at the very beginning of finding such systems and developing them into powerful tools for biotechnology. I’m proud of the resources Anthropic has invested in accelerating the public benefits of AI through the life sciences, and we’re aiming both to grow our life sciences team and to work with other scientists to extend this approach to a broad range of problems. If you have a proposal for a research collaboration or are interested in joining our life sciences team, please reach out.
Claude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme’s gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR. We don’t yet understand what this system does, but only a handful of known systems share its features, and all of them are able to cut, copy, and paste DNA. Historically, the discovery of such programmable systems has helped revolutionize medicine. CRISPR, for instance, is now the foundation of genetic medicines. But it will take much more work to learn what this system does, and whether it can be put to similar use. Read more: anthropic.com/news/claude-di…
1,724
3,433
968
30,029
5,677,935
Jeff Buchan retweeted
We’re partnering with Accenture on independent evaluation of frontier AI—part of our recent commitment to embed evaluators at Anthropic. Both we and Accenture expect to invest at least $1 billion to build capacity in this area over the next five years. anthropic.com/news/accenture…
Readers added context they thought people might want to know
Anthropic presents this as an "independent evaluation" but will directly fund Accenture's work and has a prior commercial partnership with the firm for deploying its models, including training ~30,000 Accenture professionals on Claude. anthropic.com/news/accenture… anthropic.com/news/anthropic…
889
331
675
3,674
2,869,946
Jeff Buchan retweeted
We Must Pace the Frontier: I’ve written a new essay on why the AI industry should slow down, with a three-part plan for doing so. Anthropic is unilaterally committing to the first of these steps. We’ll provide third-party evaluators with permanent, employee-level access to our systems, so that they can verify adherence to our safety measures, report on incidents, and assess models’ alignment during training. You can read the full post here: darioamodei.com/post/we-must…
10,543
16,298
11,365
87,536
77,173,160
Jeff Buchan retweeted
Today we released our latest threat intel report detailing how we detected and disrupted actors trying to misuse Claude, and why we share what we find with government partners. Effective oversight of AI starts with a clear view of how it's actually being misused so we can all make our defenses stronger. anthropic.com/threat-intelli…
1
4
30
14,038
Jeff Buchan retweeted
We're publishing our most detailed threat intelligence report to date. It covers how people tried to misuse Claude—for cyberattacks, influence operations, surveillance, biology, and building weapons—and how we found and stopped them. We disrupted every operation in the report, and used the lessons from them to strengthen our safeguards. Where appropriate, we also shared what we found with authorities and other AI companies. These cases are not typical: we’re highlighting some of the most sophisticated misuse we’ve seen. But they’re especially important to discuss, because they show us where AI misuse is headed, where our safeguards work, and where they need to improve. We’re publishing this report so others can spot the same activity on their own platforms, and so we can give the public a clearer view of how emerging threats develop. Read the report: anthropic.com/threat-intelli…
3,189
11,619
4,939
50,131
43,966,427
Jeff Buchan retweeted
There’s been a lot of speculation about where we stand on open-weights models. We’ve outlined our views in full here: anthropic.com/news/position-…
2,686
1,046
1,924
8,063
7,830,501
Jeff Buchan retweeted
We’ve received notice that the Department of Commerce has lifted export controls on Claude Fable 5 and Mythos 5. We'll begin restoring access tomorrow, and will share an update soon. We’re grateful to our users for their patience, and to everyone who worked with us on redeploying the models.
3,988
12,571
7,034
83,458
15,201,286
Jeff Buchan retweeted
We're joining @raiseus_ai as a founding partner. RAISE US is a nonprofit coalition working to strengthen the American workforce through employer-led action, AI-enabled training, and policy innovation to support the transition to transformative AI.
Today, we're launching RAISE US. America has a technology strategy for AI. It doesn't have a people strategy yet. We're here to build one. RAISE US is co-chaired by @GinaRaimondo and Eric Holcomb. We're working with governors, employers, and educators to help workers train, transition, and thrive. This works because the people building AI and the people most affected by it are at the same table. Read more: raiseus.ai #RAISEUS
242
203
55
3,192
796,842
Jeff Buchan retweeted
We’re launching Claude Corps, a national fellowship program matching people early in their careers with US nonprofits. We'll teach 1,000 people to use Claude, and pay them to use AI to advance their hosts’ missions. anthropic.com/claude-corps
582
708
222
6,898
1,096,643
Jeff Buchan retweeted
Our Advanced AI Framework sets out how governments should prepare for and prevent catastrophic risks from frontier AI systems. The government should have the authority to block or revoke the release of unsafe models, and invest in societal resilience. anthropic.com/policy-on-the-…
23
19
9
254
47,190
Jeff Buchan retweeted
An Economic Policy Framework: a proposal for how the US government should manage labor market disruption from advanced AI. We’re contributing $200 million to a new fund to sponsor major evaluations of some of these ideas. anthropic.com/policy-on-the-…
25
49
16
412
94,783
Jeff Buchan retweeted
AI is advancing at a pace our policymaking institutions were never built for—and the gap between the two is becoming the central challenge of the technology. In his latest essay, our CEO Dario Amodei lays out how to close it. We're launching three new initiatives to support the efforts he outlines.
Today I'm publishing a new essay, Policy on the AI Exponential. AI is progressing extremely fast—much faster than the policy process was built to handle. The essay lays out where I think the technology is now, and the action needed to close the gap: darioamodei.com/post/policy-…
423
448
121
5,417
1,577,105
Jeff Buchan retweeted
Today I'm publishing a new essay, Policy on the AI Exponential. AI is progressing extremely fast—much faster than the policy process was built to handle. The essay lays out where I think the technology is now, and the action needed to close the gap: darioamodei.com/post/policy-…
1,611
2,633
1,042
14,428
7,506,792
Jeff Buchan retweeted
Introducing Claude Fable 5: a Mythos-class model that we’ve made safe for general use. Its capabilities exceed those of any model we’ve ever made generally available.
4,906
14,051
9,952
103,179
57,749,030
Jeff Buchan retweeted
Small businesses are the engine of the American economy. Our 2025 US Economic Impact Report shows how Google is helping, from connecting 19.5M businesses with customers to training 350,000+ owners in digital skills. But the true impact is in the stories behind these numbers, like Atlas Automotive Repair in Oklahoma using Gemini to prep customer reports or The Boardwalk Cleaning Co. in Texas using NotebookLM as an internal knowledge base. Google is helping businesses grow in every state: economicimpact.google/
80
78
7
645
120,528